teclistamab
janssen,genmab
['multiple myeloma', 'teclistamab']
. has been published by #asco23, efficacy of teclistamab in patients with heavily pretreated, relapsed/refractory multiple myeloma, including those refractory to penta rrmm and bcma directed therapy. find it under abstract #e20044. 
We are transforming cancer research and clinical care by linking our innovative approach to drug discovery, delivery and development to our patient care program